{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T14:07:00Z","timestamp":1785247620171,"version":"3.55.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T00:00:00Z","timestamp":1600041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T00:00:00Z","timestamp":1600041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bioenerg Biomembr"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s10863-020-09850-8","type":"journal-article","created":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T19:02:58Z","timestamp":1600110178000},"page":"343-354","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["CADM1 enhances intestinal barrier function in a rat model of mild inflammatory bowel disease by inhibiting the STAT3 signaling pathway"],"prefix":"10.1007","volume":"52","author":[{"given":"Shengtao","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,14]]},"reference":[{"issue":"3","key":"9850_CR1","first-page":"395","volume":"17","author":"S Abroun","year":"2015","unstructured":"Abroun S, Saki N, Ahmadvand M, Asghari F, Salari F, Rahim F (2015) STATs: an old story, yet mesmerizing. Cell J 17(3):395\u2013411","journal-title":"Cell J"},{"issue":"5","key":"9850_CR2","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1053\/gast.2000.19576","volume":"119","author":"ED Al-Chaer","year":"2000","unstructured":"Al-Chaer ED, Kawasaki M, Pasricha PJ (2000) A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development. Gastroenterology 119(5):1276\u20131285","journal-title":"Gastroenterology"},{"issue":"3","key":"9850_CR3","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1053\/j.gastro.2003.11.055","volume":"126","author":"G Barbara","year":"2004","unstructured":"Barbara G, Stanghellini V, de Giorgio R, Cremon C, Cottrell GS, Santini D, Pasquinelli G, Morselli-Labate AM, Grady EF, Bunnett NW, Collins SM, Corinaldesi R (2004) Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 126(3):693\u2013702","journal-title":"Gastroenterology"},{"issue":"16","key":"9850_CR4","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1038\/onc.2016.403","volume":"36","author":"K Berthenet","year":"2017","unstructured":"Berthenet K, Bokhari A', Lagrange A, Marcion G, Boudesco C, Causse S, de Thonel A, Svrcek M, Goloudina AR, Dumont S, Hammann A, Biard DS, Demidov ON, Seigneuric R, Duval A, Collura A, Jego G, Garrido C (2017) HSP110 promotes colorectal cancer growth through STAT3 activation. Oncogene 36(16):2328\u20132336","journal-title":"Oncogene"},{"issue":"2","key":"9850_CR5","first-page":"2620","volume":"16","author":"H Cai","year":"2018","unstructured":"Cai H, Miao M, Wang Z (2018) miR-214-3p promotes the proliferation, migration and invasion of osteosarcoma cells by targeting CADM1. Oncol Lett 16(2):2620\u20132628","journal-title":"Oncol Lett"},{"issue":"7","key":"9850_CR6","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2982.2007.00925.x","volume":"19","author":"M Camilleri","year":"2007","unstructured":"Camilleri M, Gorman H (2007) Intestinal permeability and irritable bowel syndrome. Neurogastroenterol Motil 19(7):545\u2013552","journal-title":"Neurogastroenterol Motil"},{"issue":"6","key":"9850_CR7","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2982.2012.01921.x","volume":"24","author":"M Camilleri","year":"2012","unstructured":"Camilleri M, Madsen K, Spiller R, Greenwood-Van Meerveld B, Verne GN (2012) Intestinal barrier function in health and gastrointestinal disease. Neurogastroenterol Motil 24(6):503\u2013512","journal-title":"Neurogastroenterol Motil"},{"issue":"7","key":"9850_CR8","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.tips.2010.04.008","volume":"31","author":"JY Chang","year":"2010","unstructured":"Chang JY, Talley NJ (2010) Current and emerging therapies in irritable bowel syndrome: from pathophysiology to treatment. Trends Pharmacol Sci 31(7):326\u2013334","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"9850_CR9","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/ijc.25356","volume":"128","author":"K Chen","year":"2011","unstructured":"Chen K, Wang G, Peng L, Liu S, Fu X, Zhou Y, Yu H, Li A, Li J, Zhang S, Bai Y, Zhang Y (2011) CADM1\/TSLC1 inactivation by promoter hypermethylation is a frequent event in colorectal carcinogenesis and correlates with late stages of the disease. Int J Cancer 128(2):266\u2013273","journal-title":"Int J Cancer"},{"issue":"1","key":"9850_CR10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.prp.2017.10.003","volume":"214","author":"XQ Chu","year":"2018","unstructured":"Chu XQ, Wang J, Chen GX, Zhang GQ, Zhang DY, Cai YY (2018) Overexpression of microRNA-495 improves the intestinal mucosal barrier function by targeting STAT3 via inhibition of the JAK\/STAT3 signaling pathway in a mouse model of ulcerative colitis. Pathol Res Pract 214(1):151\u2013162","journal-title":"Pathol Res Pract"},{"issue":"2","key":"9850_CR11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.gtc.2005.02.008","volume":"34","author":"F Cremonini","year":"2005","unstructured":"Cremonini F, Talley NJ (2005) Irritable bowel syndrome: epidemiology, natural history, health care seeking and emerging risk factors. Gastroenterol Clin N Am 34(2):189\u2013204","journal-title":"Gastroenterol Clin N Am"},{"issue":"4","key":"9850_CR12","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1046\/j.1471-4159.2003.01604.x","volume":"84","author":"K Dinkel","year":"2003","unstructured":"Dinkel K, MacPherson A, Sapolsky RM (2003) Novel glucocorticoid effects on acute inflammation in the CNS. J Neurochem 84(4):705\u2013716","journal-title":"J Neurochem"},{"issue":"7","key":"9850_CR13","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1111\/j.1572-0241.2003.07542.x","volume":"98","author":"SP Dunlop","year":"2003","unstructured":"Dunlop SP, Jenkins D, Spiller RC (2003) Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome. Am J Gastroenterol 98(7):1578\u20131583","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"9850_CR14","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.3892\/mmr.2016.4978","volume":"13","author":"S Feng","year":"2016","unstructured":"Feng S et al (2016) Impaired function of the intestinal barrier in a novel sub-health rat model. Mol Med Rep 13(4):3459\u20133465","journal-title":"Mol Med Rep"},{"issue":"3","key":"9850_CR15","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/bjhp.12304","volume":"23","author":"JM Harvey","year":"2018","unstructured":"Harvey JM, Sibelli A, Chalder T, Everitt H, Moss-Morris R, Bishop FL (2018) Desperately seeking a cure: treatment seeking and appraisal in irritable bowel syndrome. Br J Health Psychol 23(3):561\u2013579","journal-title":"Br J Health Psychol"},{"issue":"33","key":"9850_CR16","doi-asserted-by":"publisher","first-page":"5500","DOI":"10.3748\/wjg.v19.i33.5500","volume":"19","author":"A Iraha","year":"2013","unstructured":"Iraha A, Chinen H, Hokama A, Yonashiro T, Kinjo T, Kishimoto K, Nakamoto M, Hirata T, Kinjo N, Higa F, Tateyama M, Kinjo F, Fujita J (2013) Fucoidan enhances intestinal barrier function by upregulating the expression of claudin-1. World J Gastroenterol 19(33):5500\u20135507","journal-title":"World J Gastroenterol"},{"issue":"7","key":"9850_CR17","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1111\/cas.14040","volume":"110","author":"T Ito","year":"2019","unstructured":"Ito T, Nakamura A, Tanaka I, Tsuboi Y, Morikawa T, Nakajima J, Takai D, Fukayama M, Sekido Y, Niki T, Matsubara D, Murakami Y (2019) CADM1 associates with hippo pathway core kinases; membranous co-expression of CADM1 and LATS2 in lung tumors predicts good prognosis. Cancer Sci 110(7):2284\u20132295","journal-title":"Cancer Sci"},{"issue":"4","key":"9850_CR18","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1053\/j.gastro.2013.07.001","volume":"145","author":"G Koukos","year":"2013","unstructured":"Koukos G, Polytarchou C, Kaplan JL, Morley\u2013Fletcher A, Gras\u2013Miralles B, Kokkotou E, Baril\u2013Dore M, Pothoulakis C, Winter HS, Iliopoulos D (2013) MicroRNA-124 regulates STAT3 expression and is down-regulated in colon tissues of pediatric patients with ulcerative colitis. Gastroenterology 145(4):842\u2013852 e842","journal-title":"Gastroenterology"},{"issue":"1","key":"9850_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.amjsurg.2008.11.039","volume":"199","author":"Y Li","year":"2010","unstructured":"Li Y, Chen Y, Zhang J, Zhu JF, Liu ZJ, Liang SY, Sun K, Liao WY, Gong JP (2010) Protective effect of glutamine-enriched early enteral nutrition on intestinal mucosal barrier injury after liver transplantation in rats. Am J Surg 199(1):35\u201342","journal-title":"Am J Surg"},{"issue":"8","key":"9850_CR20","doi-asserted-by":"crossref","first-page":"e68547","DOI":"10.1371\/journal.pone.0068547","volume":"8","author":"X Liu","year":"2013","unstructured":"Liu X, Yang G, Geng XR, Cao Y, Li N, Ma L, Chen S, Yang PC, Liu Z (2013) Microbial products induce claudin-2 to compromise gut epithelial barrier function. PLoS One 8(8):e68547","journal-title":"PLoS One"},{"key":"9850_CR21","doi-asserted-by":"crossref","unstructured":"Lovell RM, Ford AC (2012) Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 10(7):712\u2013721 e714","DOI":"10.1016\/j.cgh.2012.02.029"},{"issue":"1","key":"9850_CR22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/01.shk.0000101671.49265.cf","volume":"21","author":"MD Luyer","year":"2004","unstructured":"Luyer MD et al (2004) Pretreatment with high-fat enteral nutrition reduces endotoxin and tumor necrosis factor-alpha and preserves gut barrier function early after hemorrhagic shock. Shock 21(1):65\u201371","journal-title":"Shock"},{"key":"9850_CR23","doi-asserted-by":"crossref","unstructured":"Magadmi R, Meszaros J, Damanhouri ZA, Seward EP (2019) Secretion of mast cell inflammatory mediators is enhanced by CADM1-dependent adhesion to sensory neurons. Front Cell Neurosci 13(262)","DOI":"10.3389\/fncel.2019.00262"},{"key":"9850_CR24","doi-asserted-by":"crossref","unstructured":"Mou K et al (2019) LNMAT1 promotes invasion-metastasis Cascade in malignant melanoma by epigenetically suppressing CADM1 expression. Front Oncol 9(569)","DOI":"10.3389\/fonc.2019.00569"},{"issue":"4","key":"9850_CR25","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.crohns.2011.10.004","volume":"6","author":"R Noth","year":"2012","unstructured":"Noth R, St\u00fcber E, H\u00e4sler R, Nikolaus S, K\u00fchbacher T, Hampe J, Bewig B, Schreiber S, Arlt A (2012) Anti-TNF-alpha antibodies improve intestinal barrier function in Crohn\u2019s disease. J Crohns Colitis 6(4):464\u2013469","journal-title":"J Crohns Colitis"},{"issue":"10","key":"9850_CR26","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S1542-3565(05)00410-6","volume":"3","author":"L Ohman","year":"2005","unstructured":"Ohman L, Isaksson S, Lundgren A, Simren M, Sjovall H (2005) A controlled study of colonic immune activity and beta7+ blood T lymphocytes in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 3(10):980\u2013986","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"9850_CR27","first-page":"2401","volume":"15","author":"M Saito","year":"2018","unstructured":"Saito M, Goto A, Abe N, Saito K, Maeda D, Ohtake T, Murakami Y, Takenoshita S (2018) Decreased expression of CADM1 and CADM4 are associated with advanced stage breast cancer. Oncol Lett 15(2):2401\u20132406","journal-title":"Oncol Lett"},{"issue":"6","key":"9850_CR28","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1007\/s10620-012-2546-0","volume":"58","author":"YJ Sun","year":"2013","unstructured":"Sun YJ, Cao HJ, Song DD, Diao YG, Zhou J, Zhang TZ (2013) Probiotics can alleviate cardiopulmonary bypass-induced intestinal mucosa damage in rats. Dig Dis Sci 58(6):1528\u20131536","journal-title":"Dig Dis Sci"},{"issue":"7","key":"9850_CR29","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1136\/gutjnl-2011-301213","volume":"62","author":"C Swan","year":"2013","unstructured":"Swan C, Duroudier NP, Campbell E, Zaitoun A, Hastings M, Dukes GE, Cox J, Kelly FM, Wilde J, Lennon MG, Neal KR, Whorwell PJ, Hall IP, Spiller RC (2013) Identifying and testing candidate genetic polymorphisms in the irritable bowel syndrome (IBS): association with TNFSF15 and TNFalpha. Gut 62(7):985\u2013994","journal-title":"Gut"},{"key":"9850_CR30","doi-asserted-by":"crossref","unstructured":"Vallath S et al (2016) CADM1 inhibits squamous cell carcinoma progression by reducing STAT3 activity. Sci Rep 6(24006)","DOI":"10.1038\/srep24006"},{"key":"9850_CR31","doi-asserted-by":"crossref","unstructured":"van der Weyden L, Arends MJ, Rust AG, Poulogiannis G, McIntyre RE, Adams DJ (2012) Increased tumorigenesis associated with loss of the tumor suppressor gene Cadm1. Mol Cancer 11(29)","DOI":"10.1186\/1476-4598-11-29"},{"issue":"10","key":"9850_CR32","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1038\/s41388-018-0547-y","volume":"38","author":"N Wei","year":"2019","unstructured":"Wei N, Li J, Fang C, Chang J, Xirou V, Syrigos NK, Marks BJ, Chu E, Schmitz JC (2019) Targeting colon cancer with the novel STAT3 inhibitor bruceantinol. Oncogene 38(10):1676\u20131687","journal-title":"Oncogene"},{"issue":"12","key":"9850_CR33","volume":"7","author":"YT Xiao","year":"2016","unstructured":"Xiao YT, Wang J, Lu W, Cao Y, Cai W (2016) Downregulated expression of microRNA-124 in pediatric intestinal failure patients modulates macrophages activation by inhibiting STAT3 and AChE. Cell Death Dis 7(12):e2521","journal-title":"Cell Death Dis"},{"key":"9850_CR34","doi-asserted-by":"crossref","unstructured":"Yoneshige A, Hagiyama M, Fujita M, Ito A (2015) Pathogenic actions of cell adhesion molecule 1 in pulmonary emphysema and atopic dermatitis. Front cell. Dev Biol 3(75)","DOI":"10.3389\/fcell.2015.00075"}],"container-title":["Journal of Bioenergetics and Biomembranes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10863-020-09850-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10863-020-09850-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10863-020-09850-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T01:28:31Z","timestamp":1631582911000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10863-020-09850-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,14]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["9850"],"URL":"https:\/\/doi.org\/10.1007\/s10863-020-09850-8","relation":{},"ISSN":["0145-479X","1573-6881"],"issn-type":[{"value":"0145-479X","type":"print"},{"value":"1573-6881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,14]]},"assertion":[{"value":"8 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}